
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
Biocon Biologics and Civica, Inc. on Thursday announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States. According to the company’s statemnt, under the terms of the agreement, Biocon Biologics …